Why Aphria Looks Like a Good Buy Before the Tilray Merger
Latest Tilray and Aphria Merger News: Is It a Done Deal?
Tilray or Aphria: Which Stock Should You Buy Before the Merger?
Best Cannabis Stocks to Buy Now for 2021
Gauging the Bullish-Bearish Sentiment on Aphria
The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.
Do CGC, ACB, TLRY, and APHA Look Cheap?
With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.
Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.
ACB, APHA, CTST, and HEXO Fall on March 20
The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.
Does Cronos Group Look Expensive Compared to Its Peers?
Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.
Markets Rebound but Cannabis Stock Performance Is Mixed
Markets rebounded today after the recent sell-off fueled by US-China trade tensions.
Marijuana Movement: Why Do Celebrities Support It?
Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.
Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.
What Does President Trump Think about Marijuana?
President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”
Canaccord Genuity Raises Price Target for Canopy Growth
On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Why Vaping May Not Be a Gold Mine for Cannabis Players
In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.
Aurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.
Cannabis Industry Heats Up, Trump Might Ban Vaping
Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
Cannabis in Mexico: Legalization Bill Is Ready for Voting!
Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.
Mexico Will Attempt to Legalize Marijuana in 2020
Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.
HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.
Cannabis and Vaping Concerns: Will the Dream Go Up in Smoke?
Cannabis legalization is a vital topic in the US. Meanwhile, vaping related deaths continue to rise. Will vaping concerns kill the US cannabis dream?
Why Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.
Aurora Cannabis: What to Expect from Its Q4 Results
Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.
South Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.
Is Aphria a Good Cannabis Pick for 2020?
Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.
Cannabis 2.0: Aphria Gets Ready for Edibles Market
Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.
Gundlach Compares Cannabis to Bitcoin
Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.
Kamala Harris: Presidential Candidate for Legalizing Marijuana
Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.
Canopy Growth: New Cannabis 2.0 Products amid COVID-19
Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.
Medical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
Aurora Cannabis: Analysts’ Target Price after Its Earnings
Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.
Marijuana Legalization: South Dakota Does What Trump Said!
Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.
Vaping Concerns Grow, FDA and FTC Investigate Juul
Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.
Aphria: Why Jefferies Recommends a ‘Buy’
Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.
Canopy Gets Estimates Revised by Analysts for 2020
Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.
Valuation for Cannabis Stocks in October
The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.
Analysts’ Outlook for Cronos Group in January
Jefferies reduced the target price for Cronos Group stock to $5.3 from $7.5. The stock’s average target price is set at 12.0 Canadian dollars.
Why Aurora Cannabis Stock and Peers Are Struggling
Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note
Canopy Growth: Why PI Financial Suggests a ‘Sell’
Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.
Canopy Growth Gets an Upgrade, Constellation Books Losses
Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”
Marijuana Legalization: Minnesota Welcomes You!
Marijuana legalization is an ongoing issue in the US. Currently, the District of Columbia and 11 states have legalized cannabis. Marijuana is still illegal for recreational use in Minnesota. However, the state’s voters might favor legalization. Minnesota voters are ready for marijuana legalization Minnesota hasn’t been able to come up with a legalization decision yet. […]
Cannabis Legalization: Is It Time for the US to Act?
Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.
Opioid Crisis: Is Cannabis Legalization a Good Idea?
According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.
Why Canopy Growth Is a ‘Buy’ before Its Earnings
Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?
Cannabis Beverages: Why Canadians Can’t Wait
Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.
Why Does Jim Cramer Prefer CGC versus CRON?
Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.
No Cannabis Edibles in Three Provinces for Christmas
After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.
Will Aurora Cannabis Turn the Corner in 2020?
Despite being prepared after Canada legalized recreational cannabis in 2018, Aurora Cannabis struggled to hit its revenue numbers.
Was CGC a Big Mistake for Constellation Brands?
Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.
How Aurora Cannabis’s Valuations Compare to Its Peers’
On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.
Cannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.
Cannabis Legalization: The World Waits for the US
Cannabis legalization is spreading its roots globally. Considering that other countries are legalizing marijuana, will the US follow suit?
What’s Canopy Growth Strategy for Growth?
Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
Marijuana Legalization: What’s Happening in Utah?
Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.
Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?
Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.
Has Irwin Simon Really Turned Aphria Around?
Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.
Aurora Cannabis: Target Price and Valuation Update
So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]
Do Republicans Want to Join the Cannabis Action?
Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.
Will Marijuana Stocks Continue to Surge in June?
May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.
Aphria: Analysts’ Target Price and Ratings
While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.
Aurora Cannabis: Are Its Q4 Results Good or Bad News?
Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?
New Year Will Bring Legal Marijuana to Illinois Residents
Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.
Bruce Linton Gives Tips to Canopy’s New CEO
Bruce Linton, ex-CEO of Canopy Growth (CGC) (WEED), recently had some tips to share with the company’s recently appointed CEO, David Klein.
Marijuana: Why Did Mexico Delay Legalization?
Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.
Raymond James Foresees a Cannabis Rebound in 2020
Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]
The Market Is Sinking and Taking the Cannabis Sector Along
This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.
Marijuana Legalization Ramps Up: Is Pennsylvania Next?
Marijuana legalization is ramping up in the US. Pennsylvania legalized medical cannabis in 2016. Now, the state wants to legalize recreational cannabis.
Analysts Neutral on Aphria’s 2020 Outlook in December
Aphria has successfully impressed investors compared to other cannabis companies this year, even though the same factors have affected the entire industry.
Aurora Cannabis Releases Update on Cannabis 2.0
Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.
Cronos Group Receives Rare ‘Buy’ Rating from MKM Partners
MKM Partners analyst Bill Kirk likes Cronos Group’s healthy cash position, strong track record, and its relationship with Altria (NYSE:MO).
Vaping Cannabis or Smoking Tobacco: Burning Questions
During its latest earnings call, Aphria (APHA) stated that vapes and concentrates could form a major share of Canada’s recreational market by 2021.
Vaping Risks: Health Canada’s Warning, US Reports More Cases
Health Canada issued a statement warning people about vaping risks. There have been more illnesses, possibly caused by vaping, in several US states.
Cannabis Stocks: Will Tough Times End Soon?
Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.
Cannabis: Will Top Companies’ Earnings Be a Relief?
The cannabis earnings season has started again. Earnings season is an exciting time for investors who have been eyeing the sector.
Will Mexico Legalize Cannabis by the End of the Month?
With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.
Why Canopy Growth Acquired BioSteel Sports Nutrition
On October 2, Canopy Growth (CGC) announced its purchase of a 72% stake in BioSteel Sports Nutrition. CGC stock closed with a gain of 1.6% yesterday.
When Will Canopy Growth Become Profitable?
Canopy Growth reported a negative EBITDA of 92.1 million Canadian dollars in the first quarter of fiscal 2020. The EBITDA fell 69.2% in the second quarter.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
How Cannabis Retail’s First Year Shook Out
Recreational cannabis has been legally available to Canadians since October 2018, when Canada legalized it. Recently, the country rolled out Cannabis 2.0.
MedMen: Analysts’ Views before Its Earnings
MedMen’s disappointing fourth-quarter results caused the stock price to fall. The company missed analysts’ revenue estimates for the quarter.
Are Cannabis Edibles Coming to Maryland Soon?
Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program.
Why Canopy Growth’s New CEO Popped the Stock
Yesterday, Canopy Growth (CGC) (WEED) announced that it appointed Constellation Brands’ (STZ) CFO David Klein as its new CEO.
Raymond James Is Cautiously Optimistic about Cannabis Stocks
So far, cannabis stocks have rebounded in 2020, which investors expected. The marijuana industry struggled in 2019. Overall, the rebound will take time.
Will Hexo Continue to Struggle in 2020?
For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars.
What’s Canopy Growth’s First & Free Brand About?
Yesterday, BNB Bloomberg reported that Canopy Growth (CGC) (WEED) had officially entered the US CBD market with its First & Free brand.
Cannabis Sales Decline Across Canada—Why?
In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.
OrganiGram Receives Expansion License from Health Canada
On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.
Why Does Jim Cramer Like Cronos Group and Aphria?
Cronos Group and Aphria are Jim Cramer’s top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors’ faith in the sector.
Cannabis Corruption in the US: Trouble before Elections?
Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.
Aphria’s Upcoming Earnings, Analysts Recommend a Buy
Vermont Could See Marijuana Sales in 2020
Marijuana is legal in Vermont for medical and recreational use. However, there are some limitations. The state doesn’t allow marijuana sales yet.
Marijuana Sales Soar amid Coronavirus Pandemic
Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.
Aurora Cannabis: Q3 Revenue Beat the Estimates
Aurora Cannabis saw less of an impact from COVID-19 in the third quarter. Cannabis is an essential item amid the pandemic.
Marijuana Legalization Proceeds in Montana amid COVID-19
New Approach Montana resumed its marijuana legalization campaign in May. The group submitted plenty of signatures and qualified for the November ballot.
OrganiGram Stock Falls after Disappointing Q3 Earnings
Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.
Aurora Cannabis Appoints New Chief Commercial Officer
As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.